Scientific American online recently posted a well written article about hyperbaric oxygen therapy and its emergence in treating varied and new conditions.  Conditions, also know as “off-label” or “research conditions” were listed as having positive benefit from treatment with HBOT as a primary or adjuvant therapy.  The list included breast and prostate cancers, neurological diseases, vascular diseases (vascular dementia and stroke), bone healing, insulin sensitivity and cholesterol crystal embolism (CCE).

Read more:  Hyperbaric Oxygen Therapy: A spectrum of emerging treatments

Related Posts